Skip to content

Clinical trials

Completed Anxiety Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Status: Completed Country / region: Australia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20052
20063
20072
20081
20092
20131
20151
20171
20191
20201
20213
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Queensland4
Bayside Health2
University of Melbourne2
AstraZeneca1
Australian and New Zealand Intensive Care Research Centre1
Bod Australia1
Canadian Cancer Trials Group1
Chr Hansen1
Eli Lilly and Company1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders24
Generalized Anxiety Disorder3
Autism Spectrum Disorder2
Cognitive Dysfunction2
Fatigue2
Major Depressive Disorder2
Sleep Wake Disorders2
Alcoholism1
Attention Deficit and Disruptive Behavior Disorders1
COVID-191

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.